Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis, Chronic Active”

201 trials

Showing 20 of 201 results

Testing effectiveness (Phase 2)Study completedNCT04535544
What this trial is testing

JNJ-73763989 + Nucleos(t)Ide Analog in Participants Co-Infected With Hepatitis B and Hepatitis D Virus

Who this might be right for
Hepatitis D, Chronic
Janssen Research & Development, LLC 52
Post-approval studies (Phase 4)Study completedNCT00629967
What this trial is testing

Trial of 24-Week Versus 48-Week Courses of Peginterferon Plus Ribavirin for HCV Genotype-1 Patients

Who this might be right for
Chronic Hepatitis CGenotype
Kaohsiung Medical University Chung-Ho Memorial Hospital 200
Testing effectiveness (Phase 2)Study completedNCT01180790
What this trial is testing

Safety, Tolerability, and Antiviral Activity of ACH-0141625 or Placebo in Combination With Peginterferon and Ribavirin in Hepatitis C Virus (HCV) Positive Participants

Who this might be right for
Hepatitis C
Alexion Pharmaceuticals, Inc. 122
Testing effectiveness (Phase 2)Study completedNCT01026610
What this trial is testing

Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
LG Life Sciences 115
Large-scale testing (Phase 3)Study completedNCT03833362
What this trial is testing

Efficacy and Safety of Narlaprevir Used in Combination With Ritonavir in Treatment-Naïve and Failed Prior Treatment With Pegylated Interferon/Ribavirin Patients With Chronic Hepatitis C Genotype 1 (PIONEER - Study)

Who this might be right for
Hepatitis C
R-Pharm 420
Early research (Phase 1)Study completedNCT02185794
What this trial is testing

Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Voxilaprevir in Adults With Chronic Hepatitis C Virus Infection

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 101
Early research (Phase 1)Study completedNCT02014571
What this trial is testing

Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of Repeat Doses of GSK2878175 in Subjects With Chronic Hepatitis C.

Who this might be right for
Hepatitis C, Chronic
GlaxoSmithKline 37
Testing effectiveness (Phase 2)UnknownNCT02997878
What this trial is testing

Selected Mesenchymal Stromal Cells to Reduce Inflammation in Patients With PSC and AIH

Who this might be right for
Cholangitis, SclerosingHepatitis, Autoimmune
University of Birmingham 18
Early research (Phase 1)Study completedNCT04248426
What this trial is testing

Double-Blinded Study for Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ATI-2173 in Healthy Subjects and Subjects With Chronic Hepatitis B Virus Infection

Who this might be right for
Hepatitis B, Chronic
Antios Therapeutics, Inc 88
Testing effectiveness (Phase 2)Looking for participantsNCT07096193
What this trial is testing

Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta Virus

Who this might be right for
Chronic Hepatitis Delta
Gilead Sciences 200
Testing effectiveness (Phase 2)Study completedNCT00227435
What this trial is testing

Dose Escalation Study to Evaluate the Safety and Antiviral Activity of Val-mCyd in Adults With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Merck Sharp & Dohme LLC
Post-approval studies (Phase 4)Study completedNCT06000657
What this trial is testing

Efficacy and Safety of Switching to Vemliver From Entecavir in Chronic Hepatitis B Patients Previously Treated With Entecavir

Who this might be right for
Hepatitis B, Chronic
Daewoong Pharmaceutical Co. LTD. 196
Post-approval studies (Phase 4)Study completedNCT01277601
What this trial is testing

Efficacy & Safety of Tenofovir Disoproxil Fumarate (TDF) Plus Peginterferon α-2a (Peg-IFN) Versus TDF or Peg-IFN Monotherapy in Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Gilead Sciences 751
Testing effectiveness (Phase 2)Study completedNCT04507269
What this trial is testing

Study of VIR-2218 in Patients With Chronic Hepatitis B in Mainland China

Who this might be right for
Hepatitis B, Chronic
Brii Biosciences Limited 21
Testing effectiveness (Phase 2)Study completedNCT01353911
What this trial is testing

Grazoprevir (MK-5172) Administered With Peginterferon and Ribavirin in Treatment-Naïve Participants With Chronic Hepatitis C (MK-5172-003)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 368
Early research (Phase 1)Study completedNCT00793793
What this trial is testing

Safety, Antiviral Activity and PK of MRD of BI 201335 in Chronic Hepatitis C Patients Both Treatment Naive and -Experienced

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 96
Testing effectiveness (Phase 2)Study completedNCT00118768
What this trial is testing

Evaluate the Combination of Pegylated Interferon Alfa Plus Valopicitabine in Patients With Hepatitis C

Who this might be right for
Chronic Hepatitis C
Merck Sharp & Dohme LLC 175
Testing effectiveness (Phase 2)Study completedNCT03672188
What this trial is testing

Study of VIR-2218 in Healthy Subjects and Patients With Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Vir Biotechnology, Inc. 82
Testing effectiveness (Phase 2)Study completedNCT01483742
What this trial is testing

Ritonavir-Boosted Danoprevir and RO5024048 in Different Combinations in Null Responder or Treatment-Naïve Patients With Chronic Hepatitis C and Compensated Cirrhosis

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 43
Testing effectiveness (Phase 2)Study completedNCT05734807
What this trial is testing

Evaluate the Antiviral Activity and Safety of HH-003 in Chronic Hepatitis B Subjects With Low-level Viremia

Who this might be right for
Chronic HBV Infection
Huahui Health 74
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation